Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Hypertension. 2012 Apr 16;59(6):1139–1144. doi: 10.1161/HYPERTENSIONAHA.112.192120

Figure 4.

Figure 4

Effect of the phosphodiesterase type 2 inhibitor BAY-60-7550 (10−6mol/L) added to the macula densa on the attenuation of TGF by CORM-3 (5×10−5mol/L). BAY-60-7550 did not prevent the attenuation of TGF by CORM-3. ** P < 0.01, *** P < 0.001.